Skip to main content
High RiskFDAfda-F-1907-2018OTHER

equate High Performance Protein Shake: Chocolate, Naturally & Artificially Flavored, ready to drink; 11 FL OZ (325 mL), sold in 12 pack...

Units Affected
7,244
Recall Date
July 20, 2018
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1907-2018.

Reports of off odor and off taste in Equate High Performance Protein Shake Chocolate led to recall of two lots of the product.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1907-2018.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact California Natural Products or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1907-2018.

California Natural Products

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

California Natural Products Recall FAQ

California Natural Products is the subject of a snacks & candy safety report: equate High Performance Protein Shake: Chocolate, Naturally & Artificially Flavored, ready to drink; 11 FL OZ (325 mL), sold in 12 pack.... The notice was published on July 20, 2018 by the U.S. Food and Drug Administration (FDA). Approximately 7,244 units are potentially affected.